US Stock MarketDetailed Quotes
GHRS GH Research
- 9.280
- +0.180+1.98%
Close Nov 27 16:00 ET
- 9.290
- +0.010+0.11%
Post 17:24 ET
482.82MMarket Cap-11746P/E (TTM)
9.400High8.670Low58.32KVolume9.160Open9.100Pre Close522.04KTurnover0.56%Turnover RatioLossP/E (Static)52.03MShares14.99052wk High2.55P/B96.20MFloat Cap5.05052wk Low--Dividend TTM10.37MShs Float30.430Historical High--Div YieldTTM8.02%Amplitude5.050Historical Low8.950Avg Price1Lot Size
About GH Research Company
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch?nharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Company Profile
SymbolGHRS
Company NameGH Research
Listing DateJun 25, 2021
Issue Price16.00
Founded2021
CEODr. Theis Terwey
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
AddressJoshua Dawson House,Dawson Street
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-437-8334
Websitehttp://www.ghres.com
Company Executives
- Name
- Position
- Salary
- Dr. Theis Terwey
- Chief Executive Officer
- --
- Aaron Cameron
- Chief Operating Officer
- --
- Dr. Velichka Valcheva, M.D.
- Chief Medical Officer
- --
- Julie Ryan
- Vice President, Finance
- --
- Michael Forer
- Vice Chairman of the Board
- --
- Florian Schonharting
- Chairman of the Board
- --
- Magnus Halle
- Managing Director, Ireland
- --
- Dr. Duncan Moore, PhD
- Independent Director
- --
- Dermot Hanley
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data